Anti-TNFSF2/TNFa Antibody (CertolizumAb)
Catalog No.
F1049
Anti-TNFSF2/TNFa Antibody (CertolizumAb)
Featured Products
Certolizumab pegol (Certolizumab) is a recombinant, pegylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumor necrosis factor-α (TNF-α). Certolizumab pegol is indicated for research in rheumatoid arthritis and Crohn's disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
428863-50-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Certolizumab pegol, Cimzia, CDP870
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01375
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF2 / TNFa
Please avoid freeze-thaw cycles.